Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Glass

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Elife|March 20, 2018
Protecting the nerve terminalsJonathan D Glass
Experimental Neurology|October 29, 2011
New drugs for ALS: how do we get there?Jonathan D Glass
Journal of the Neurological Sciences|May 14, 2004
Wallerian degeneration as a window to peripheral neuropathyJonathan D Glass
Journal of the Peripheral Nervous System : JPNS|January 3, 2013
The ultimate question: why do axons degenerate? A tribute to the work and mentorship of John W. Griffin, MDJonathan D Glass
Neurology|July 1, 2011
Comment: The increasing complexity of phenotype-genotype correlations in CMTJonathan D Glass
Journal of Neuropathology and Experimental Neurology|October 31, 2021
Re: The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol 2021;80(3):210-9Jonathan D Glass
Cerebrum : the Dana Forum on Brain Science|March 1, 2013
The promise and the reality of stem-cell therapies for neurodegenerative diseasesJonathan D Glass
Neurology|February 26, 2016
Calming the excitement in ALSJonathan D Glass
The Journal of Clinical Investigation|October 19, 2020
Stathmin-2: adding another piece to the puzzle of TDP-43 proteinopathies and neurodegenerationJonathan D Glass
Nature Biotechnology|May 13, 2015
Erratum: Modeling the course of amyotrophic lateral sclerosisChristina Fournier, Jonathan D Glass
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Elife|March 20, 2018
Protecting the nerve terminalsJonathan D Glass
Experimental Neurology|October 29, 2011
New drugs for ALS: how do we get there?Jonathan D Glass
Journal of the Neurological Sciences|May 14, 2004
Wallerian degeneration as a window to peripheral neuropathyJonathan D Glass
Journal of the Peripheral Nervous System : JPNS|January 3, 2013
The ultimate question: why do axons degenerate? A tribute to the work and mentorship of John W. Griffin, MDJonathan D Glass
Neurology|July 1, 2011
Comment: The increasing complexity of phenotype-genotype correlations in CMTJonathan D Glass
Journal of Neuropathology and Experimental Neurology|October 31, 2021
Re: The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol 2021;80(3):210-9Jonathan D Glass
Cerebrum : the Dana Forum on Brain Science|March 1, 2013
The promise and the reality of stem-cell therapies for neurodegenerative diseasesJonathan D Glass
Neurology|February 26, 2016
Calming the excitement in ALSJonathan D Glass
The Journal of Clinical Investigation|October 19, 2020
Stathmin-2: adding another piece to the puzzle of TDP-43 proteinopathies and neurodegenerationJonathan D Glass
Nature Biotechnology|May 13, 2015
Erratum: Modeling the course of amyotrophic lateral sclerosisChristina Fournier, Jonathan D Glass
Pageof 18